NASDAQ
Bellerophon Therapeutics, Inc. (BLPH) has a current ratio of 1.40x as of Monday, May 25, 2026. This represents a 57.96% decrease compared to its 12-month average of 3.33x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.